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This paper gives an overview of the recent advances in engineering the central carbon metabolism of the
industrially important bacteria Escherichia coli, Bacillus subtilis, Corynobacterium glutamicum, Streptomyces spp.,
Lactococcus lactis and other lactic acid bacteria. All of them are established producers of important classes of
products, e.g. proteins, amino acids, organic acids, antibiotics, high-value metabolites for the food industry and also,
promising producers of a large number of industrially or therapeutically important chemicals. Optimization of
existing or introduction of new cellular processes in these microorganisms is often achieved through manipulation
of targets that reside at major points of central metabolic pathways, such as glycolysis, gluconeogenesis, the
pentose phosphate pathway and the tricarboxylic acid cycle with the glyoxylate shunt. Based on the huge progress
made in recent years in biochemical, genetic and regulatory studies, new fascinating engineering approaches aim at
ensuring an optimal carbon and energy flow within central metabolism in order to achieve optimized metabolite
production.Introduction
Metabolic engineering is a field that encompasses detailed
metabolic analysis aiming at identifying targets for ma-
nipulation through recombinant DNA technology for the
improvement and/or design of cells [1]. Metabolic engin-
eering is principally concerned with understanding the
regulation of metabolic systems as a whole.
The term “central carbon metabolism” (CCM) describes
the integration of pathways of transport and oxidation of
main carbon sources inside the cell. In most bacteria, the
main pathways of the CCM are those of the phosphotrans-
ferase system (PTS), glycolysis, gluconeogenesis, pentose
phosphate (PP) pathway, and the tricarboxylic acid cycle
(TCA) with the glyoxylate bypass. As a whole, the system
has a complex structure and it is regulated by complex
networks of reactions. The knowledge about regulation in
CCM has great industrial relevance as it may allow the en-
gineering of selected metabolic steps to reroute carbon
fluxes toward precursors for industrially important meta-
bolites [2]. This kind of metabolic engineering however isCorrespondence: mp2000@vet.auth.gr
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reproduction in any medium, provided the ora difficult task as there is still significant lack of knowledge
regarding the regulation of central carbon metabolism flux
for many industrially important bacteria. Escherichia coli is
by far the most extensively studied bacterium in this field.
Most recently acquired knowledge provides fundamental
insights into the regulation of fluxes in CCM through tran-
scriptional control [3], a finding that may hold for other
bacteria as well, and is expected to have a significant im-
pact in industrial biotechnology.
The field of metabolic engineering is broad and diverse
and rapidly expanding and the reader will find in the litera-
ture a number of excellent reviews that cover the area from
different perspectives. The present, aims to give an overview
of the recent advances in engineering the CCM of the in-
dustrially important bacteria E. coli, Bacillus subtilis,
Corynobacterium glutamicum, Streptomyces spp., Lactococ-
cus lactis and other lactic acid bacteria. All of them are
established producers of important classes of products, e.g.
proteins, amino acids, organic acids, antibiotics, high-value
metabolites for the food industry and also, promising pro-
ducers of a large number of industrially or therapeutically
important chemicals. Optimization or introduction of new
cellular processes in these microorganisms is often achieved
through manipulation of targets that reside at major pointstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Simplified representation of the central carbon
metabolism of E. coli. (A) glycolysis and gluconeogenesis, (B)
anaplerotic reactions, (C) acetate formation and assimilation, (D) TCA
cycle, (E) Glyoxylate shunt, (F) PP pathway. The dotted line arrow
from oxaloacetate to pyruvate indicates the anaplerotic reaction
catalysed by pyruvate carboxylase. The broken line arrows indicate
the removal of metabolites.
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manipulations of such points will be discussed in this
review.
Escherichia coli
E. coli, a Gram-negative bacterium, is being used widely
today in a large number of biotechnological processes.
The ease of cultivation –it grows quickly in minimal
media, as well as its ability to metabolize both pentoses
and hexoses [4], have made it the bacterium of choice
for research and over the years the wealth of information
in genomics, proteomics and metabolism have led it to
be regarded as the prime prokaryotic model [5]. Many
feasible genetic tools have been developed and the clon-
ing methodologies for E. coli developed for the produc-
tion of foreign proteins established it as a “cell-factory”.
E. coli is the organism of choice for the expression of a
wide variety of recombinant proteins for industrial,
therapeutic and diagnostic applications. Apart from pro-
teins, E.coli has been shown to be a suitable host for the
production of many other valuable metabolites.
The CCM of E. coli and specifically the metabolism of
glucose are intensively studied and well known topics
[6,7]. Glucose metabolism starts with its uptake via the
PTS and proceeds with several interconnected pathways
with the major being: glycolysis, gluconeogenesis, the pen-
tose-monophosphate bypass with the Entner-Dudoroff
pathway, the TCA cycle with the glyoxylate bypass, ana-
plerotic reactions and acetate production and assimilation
(Figure 1). The network controlling the carbon uptake
integrates metabolism, signal transduction and gene ex-
pression [8]. The extensive knowledge gained on E. coli
CCM [6] offers key advantages in metabolic engineering
efforts that aim at achieving increased metabolite produc-
tion. Such efforts have been focused intensively rather on
the upper part of the carbon assimilation network, consist-
ing of glycolysis and glyconeogenesis and their genetic and
metabolic regulation.
The terminal stages of glycolysis in E. coli involve com-
plex interplays. PEP conversion is coupled to two metabolic
processes: PEP may give rise to pyruvate by pyruvate kinase
(PK) in the PTS or it may give rise to oxaloacetate by the
PEP carboxylase (ppc)-catalyzed anaplerotic reaction.
Pyruvate, the end-product of glycolysis, is oxidized to
acetyl-CoA and CO2 by the pyruvate dehydrogenase
complex. Acetyl-CoA participates in a large number of
reactions either as substrate or as product: it can enter
the TCA cycle, it can be used in fatty acid and triglycer-
ides biosynthesis and it can be used in acetate biosyn-
thesis. Acetyl-CoA connects the glycolysis and the
acetate metabolism pathways with the TCA cycle and
the glyoxylate shunt. Acetyl-CoA is therefore a key factor
in determining biomass formation, the redox balance
and energy yield. Moreover, the acetate-acetyl-CoA nodedetermines a large part of the control exerted by central
metabolism on the performance of many microbial pro-
cesses [9].
The final products of glycolysis PEP and pyruvate enter
the TCA cycle via acetyl-CoA and via the formation of oxa-
loacetate by carboxylation. This route, referred to as ana-
plerosis, replenish the intermediates of the TCA cycle that
were used for anabolic purposes. Under gluconeogenic
conditions, the TCA cycle intermediates oxaloacetate or
malate are converted to pyruvate and PEP by decarboxyl-
ation and this way the PEP-pyruvate-axaloacetate node
provides the precursors for gluconeogenesis. Therefore, the
metabolic link between glycolysis, gluconeogenesis and the
TCA cycle is represented by the PEP-pyruvate-oxaloacetate
node [6].
Key points of the above processes that represent main
problems related to the use of E. coli as a cell factory are
the following: a) PEP availability as a building block for
the production of other valuable compounds is reduced;
b) acetyl-CoA accumulation can affect the utilization of
glucose by causing accumulation of pyruvate and enhan-
cing acetate production; and c) acetate accumulation
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the glucose used could appear as acetate.
Acetate co-production by E. coli in recombinant protein
fermentations represents a serious problem that has been
discussed by many authors [10]. Apart from the diversion
of carbon that might otherwise be used in synthesis of bio-
mass or the protein product, acetate production causes a
number of other problems since it inhibits growth even at
very low concentrations, e.g. 0.5 g/l [11], it inhibits protein
formation [12], it affects proteins and genes involved in
stress response and regulation processes [13], it interferes
with methionine biosynthesis [14], it interferes with bacter-
ial energetics as it dissipates the pH component of the
membrane potential, and it causes pH control problems in
fermentation [15]. It has been shown that acetate is more
inhibitory to recombinant protein producing strains than
to wild-type ones as the threshold growth rate for the
onset of acetate production is lower in the first [16]. Thus,
control of acetate formation is of paramount importance
in recombinant protein production systems with E. coli.
The rate at which acetate forms is directly related to
the growth rate and the glucose consumption rate. Since
in the common for E. coli operational mode of fed-batch
culture, the growth rate is determined by the feeding rate
of the limiting substrate, E. coli generates acetate when
glucose is the limiting substrate and cells grow above a
threshold growth rate [10]. In the applied fully aerobic
conditions, the availability of oxygen is not related to the
formation of acetate however, the rate of oxygen uptake
is the factor that determines it and most process and
genetic engineering strategies aim to facilitate the appro-
priate balance between growth rate and oxygen uptake.
Acetate formation is influenced by operational aspects
of E. coli processes e.g. feeding strategies in fed-batch
fermentations, and by the composition of the culture
medium. There have been many attempts to control
acetate formation by process modifications that mainly
aim to control the growth rate of the microorganism
[10]. These approaches will not be discussed in the
present review. Similarly, there have been many attempts
to reduce acetate formation by genetic engineering that
use different approaches and strategies. These strategies
focus either on the uptake and consumption rates of glu-
cose or on the flux from the central pathways to acetate
or finally on the metabolic and regulatory mechanisms
that lead to accumulation of acetate.
Picon et al. [17] studied the effects of changes made in
the glucose uptake capacity on the flux distribution to
the desired end product β-galactosidase and to acetate.
The lack of one of the components (IICB(Glc) protein)
of the glucose-PTS reduced the growth rate significantly.
However, β -galactosidase production had no effect on
growth rate. The constructed strain directed more car-
bon into biomass and carbon dioxide, and less intoacetate. β -galactosidase was produced in amounts not
significantly different from the wild-type strain from half
the amount of glucose.
De Anda et al. [18] studied the effect of replacing the
glucose-PTS with an alternate glucose transport activity
on growth kinetics, acetate accumulation and production
of two model recombinant proteins. The engineered
strain maintained similar production and growth rate
capabilities while reducing acetate accumulation. Specific
glucose consumption rate was lower and product yield
on glucose was higher in the engineered strain in fed-
batch culture. Altogether, strains with the engineered
glucose uptake system showed improved process per-
formance parameters for recombinant protein produc-
tion over the wild-type strain.
The approach of Wong et al. [19] to reducing acetate
accumulation was to disable the PEP:PTS (phosphoene-
lopyruvate:phosphotransferase system) by deleting the
ptsHI operon in the wild-type E. coli strain GJT001. The
mutation caused a severe reduction in growth rate and
glucose uptake rate in glucose-supplemented minimal
medium, which confirmed the mutation, and eliminated
acetate accumulation. The mutant strain apparently
metabolized glucose by a non-PTS mechanism followed
by phosphorylation by glucokinase. The ptsHI mutant of
GJT001 resulted in reduced acetate accumulation, which
led to significant improvements in recombinant protein
production in batch bioreactors.
Lara et al. [20] worked with an E. coli strain lacking
the PEP:PTS, at glucose concentrations of up to 100 g/L
in batch mode and showed that high cell and recombin-
ant protein concentrations are attainable in simple batch
cultures by circumventing overflow metabolism through
metabolic engineering. At the highest glucose concentra-
tion tested, acetate accumulated to a maximum of
13.6 g/L for the parental strain whereas a maximum con-
centration of only 2 g/L was observed for the engineered
strain. This represents a novel and valuable alternative to
classical bioprocessing approaches.
The main route for acetate production is from
acetyl-CoA through acetyl-phosphate by the two
enzymes phosphotransacetylase (pta) and acetate kin-
ase (ack). The second approach of redirecting the flow
of carbon to acetate may involve the elimination of
the activity of these two enzymes as described in the
works of Bauer et al. [21], Hahm et al. [22], and
Chang et al. [23]. In a similar approach, Kim and Cha
[24] reported the use of an antisense RNA strategy to
partially block the synthesis of pta and ack and the
resulted improved recombinant protein production.
However, in the recent work of Castano-Cerezo et al.
[9], deletion of pta was shown to strongly affect the
expression of several genes related to central meta-
bolic pathways, as well as the ability of E. coli to
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decreased acetyl-CoA synthetase, glyoxylate shunt and
gluconeogenic activities.
As the accumulation of pyruvate signals the onset of
acetate formation, in the third approach that focuses on
the metabolic and regulatory mechanisms that lead to
accumulation of acetate, either pyruvate or the glycolytic
products should be diverted to where carbon is needed:
in the TCA cycle. Vemuri and co-workers [25] showed
that several genes involved in the TCA cycle and respir-
ation are repressed as the glucose uptake rate increases
and deletion of the gene coding for the regulatory pro-
tein ArcA resulted in reduction of the produced acetate
and increase of biomass due to the increased capacities
of the TCA cycle and the respiratory chain.
The diversion of carbon from acetate or its precursors to
the TCA cycle can be accomplished by manipulating the
expression levels of the anaplerotic enzyme PEP carboxyl-
ase. Overexpressing the native PEP carboxylase reduced
acetate formation by 60 % in shake flasks cultures grown
at low cell density and significantly increased biomass yield
[26,27]. However, PEP carboxylase (ppc) overexpression
diminished the supply of PEP needed for the PTS-
mediated uptake of glucose and decreased the growth rate
of the organism. The anaplerotic function of PEP carboxyl-
ase was also shown to be fully restored by expression of
pyruvate carboxylases in ppc mutants [28]. The result was
an increased carbon flux to oxaloacetate during growth of
E. coli on glucose under both aerobic and anaerobic condi-
tions [28,29]. Under aerobic conditions, the flux redirec-
tion resulted in a 50 % increase in yield of biomass while
glucose uptake and specific growth rates remained un-
altered. Similarly, March and co-workers [30] in their work
with an E. coli strain containing pyruvate carboxylase (pyc)
reported a 60 % decrease of acetate while the protein yield
increased by 68 %, while Vemuri et al. [31] reported an
80 % reduction of acetate upon introduction of heterol-
ogous pyruvate carboxylase.
Acetate formation is affected by the NADH/NAD ratio.
Vemuri et al. [32] reported the complete elimination of
acetate and a 10 % increase in protein yield in an arcA
mutant by reducing the redox ratio through expression
of the water-forming NADH oxidase from Streptococcus
pneumoniae.
The PEP-pyruvate-oxaloacetate node [6] is receiving
increased attention and this is mostly driven by the need
to manipulate the carbon flux through the node for
improved production in various biotechnological pro-
cesses. Such a case is the production of succinate by E. coli
that involves extensive anaplerotic fluxes. Various meta-
bolic engineering approaches have been implemented suc-
cessfully, including everexpression of the native ppc [33],
the NAD-dependent malic enzyme ScfA [34], a heterol-
ogous PEP carboxykinase (pck) [35], use of alternativeglucose transport systems to increase energy efficiency by
eliminating the need to produce additional PEP from pyru-
vate, a reaction that requires two ATP equivalents [36] and
combined approaches such as overexpression of heterol-
ogous pck and inactivation of the PEP-dependent PTS
[37]. Another strategy for the efficient conversion of glu-
cose to pyruvate was to combine mutations to minimize
ATP yield, cell growth and CO2 production with muta-
tions to eliminate acetate production [38].
An important focus area for metabolic engineering of
the PEP-pyruvate-oxaloacetate node is the production of
aromatic compounds. The shikimic acid (SA) pathway is
the common route leading to the biosysnthesis of aro-
matic compounds in bacteria as well as in several
eukaryotic organisms and plants [39]. In E. coli, the first
step in this pathway is the fusion of PEP precursors and
erythrose-4P into 3-deoxy-D-arabinoheptulosonate-7P
(DAHP) by the DAHP synthase [40]. Since PEP is also
required for the PTS-glucose uptake and for anaplerosis,
it is obvious that enhancing PEP availability is necessary
for high-level production of aromatic compounds in E.
coli. Metabolic engineering approaches that aimed suc-
cessfully at increased PEP availability include inactivation
of the PTS operon, installation of non-PTS glucose
transporters like glucose facilitators, and transformation
with plasmids that carry the tktA and ppA genes, coding
for transketolase I and PEP synthase, respectively, in
order to increase availability of the intermediates E4P
and PEP [41-44]. Combining CCM modifications with
SA pathway modifications, like partial or total blockage
of the SA flux into chorismic acid (CHA), e.g. by inacti-
vating aroK and aroL genes, resulted in significant
increases in SA [45] or anthranilate accumulation [46].
The metabolic network of the TCA cycle and the
glyoxylate bypass in E. coli has been the focus of various
engineering strategies during the last decade due to the
tremendous increase of interest for the efficient produc-
tion of high-value platform chemicals and building
blocks for bio-based polymers. Succinic acid is a plat-
form chemical that can be converted to 1,4-butanediol,
γ-butyrolactone, tetrahydrofuran, and other chemicals of
industrial importance. Succinic acid formation occurs
primarily through the reductive branch of the TCA cycle
(fermentative pathway) during anaerobic conditions, and
the glyoxylate bypass. However, due to insufficient redu-
cing power, wild-type E. coli can produce only a small
amount of acid (7.8 %) through the fermentative pathway
[47,48]. Succinic acid production was improved either by
introducing genetically modified metabolic pathways that
enhance key enzyme activity or by deleting or inhibiting
competitive to succinic acid pathways [49]. Successful
examples of the first strategy include the overexpression
of ppc [33], of heterologous pck [35], of pyc [50], that led
to significant increases -even 6.5-fold-in the production
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involves the deactivation of αdhE (aldehyde dehydrogen-
ase), ldhA (lactate dehydrogenase) and αck-ptα (acetate
kinase-phosphate acetyltransferase) from the central
metabolic pathway and activation of the glyoxylate by-
pass through the inactivation of iclR that encodes a tran-
scriptional repressor protein of the glyoxylate bypass
[51]. Lin et al. [47] constructed a mutant E. coli strain by
deletion of αck-ptα, iclR, and ptsG genes and overexpres-
sion of the ppc gene and achieved high-level succinate
production under aerobic conditions.
The CCM includes also the pentose-phosphate (PP)
pathway. In the oxidative branch of the pathway which
supplies reducing power for cellular biosynthetic pro-
cesses, NADPH is generated via oxidation of glucose-6-
phosphate (G-6P) by G-6P dehydrogenase (G6PDH,
encoded by zwf). The non-oxidative branch includes the
interconversion of ribulose-5P, ribose-5P and xylulose-5P
and the transfer of either a glycoaldehyde group or a dihy-
droxyacetone group among sugar phosphates by trans-
ketolase and transaldolase, respectively. Engineering the
PP pathway has received attention either for the redirec-
tion of the carbon flux to mainstream glycolytic pathway
or for overproduction of NADPH. Knocking out zwf
resulted in a non-operational PP pathway and an increased
TCA activity in the work of Zhao et al. [52]. Few studies
however have been focused on G-6P dehydrogenase as a
key enzyme that activates the PP pathway. Homologous
co-overexpression of zwf and glpX (encodes for FBPase II)
activated the PP pathway and increased the NADPH-
dependent hydrogen production to 2.32-fold [53]. Over-
production of NADPH is of primal importance for various
synthetic pathways e.g. for the efficient production of poly
(3-hydroxybutyrate) (PHB). Since NADPH is mainly
formed in the PP in E. coli, knocking out phosphoglucose
isomerase (pgi) forced the carbon flow into the PP pathway
and enhanced NADPH production but repressed cell
growth [54]. Cell growth was recovered to some extend by
introducing a NADPH-consuming pathway, such as the
PHB synthetic pathway and efficient PHB production was
achieved by appropriately controlling the glucose concen-
tration of the substrate.Bacillus subtilis
Bacillus spp. are used industrially for the production of
enzymes (amylases, lipases, proteases), vitamins, antibio-
tics, purine nucleotides, poly-γ-glutamic acid, D-ribose,
PHB and other metabolites. B. subtilis is able to
metabolize a wide range of carbohydrates, including
monosaccharides (e.g., glucose, xylose), oligosaccharides
(e.g., maltodextrins, cellodextrins), and polysaccharides
(e.g., starch)- but not cellulose [55,56]. B. subtilis has
been an attractive host for the expression of foreignproteins (e.g. enzymes) on an industrial scale due to its
ability to transport them out of the cell through secre-
tion systems.
The TCA cycle is one of the major routes of carbon ca-
tabolism in B. subtilis [57]. Anaplerotic reactions con-
tribute to the flux through the TCA cycle. The reactions
at the interface between the lower part of glycolysis and
the TCA cycle were identified as an important metabolic
subsystem in this organism [58].
B. subtilis is an important model microorganism in the
field of metabolic engineering for the production of ribo-
flavin [59]. The PP pathway and the pyruvate shunt were
identified as major pathways of glucose catabolism in a re-
combinant riboflavin-producing B. subtilis strain [60].
Reactions connecting the TCA cycle and glycolysis, cata-
lyzed by the malic enzyme and PEP carboxykinase were
found to consume up to 23 % of the metabolized glucose.
The overall flux distribution suggested that B. subtilis me-
tabolism has an unusually high capacity for the reoxidation
of NADPH. Under the conditions investigated [60], ribo-
flavin formation in B. subtilis is limited by the fluxes
through the biosynthetic rather than the central carbon
pathways, suggesting a focus for metabolic engineering of
this system. Therefore, overexpression of enzymes (e.g.
G6PDH and 6PGDH) that facilitate the route of carbon
flow towards the PP pathway increased the pool of ribu-
lose-5P which is a precursor for riboflavin biosynthesis
and led to increased riboflavin yields [61-63].
It is expected that B. subtilis will play an important
role in the process of converting biomass into biocom-
modities [64,65]. In this view, modifications of the het-
erofermentative and homofermentative metabolism of
the organism have been reported recently, along with the
construction of recombinant cellulolytic strains. Romero
and co-workers [66] identified a key physiological role in
LDH for glucose consumption under heterofermentative
metabolism. By inactivating the ldh gene and eliminating
butanediol biosynthesis, the resulting recombinant B.
subtilis strain produced enthanol as the sole fermenta-
tion product. To increase L-lactate production, Romero-
Garcia and co-workers [67] constructed the B. subtilis
CH1 alsS- strain that lacks the ability to synthesize 2,3-
butanediol. Inactivation of the pathway that competed
for pyruvate availability, led to a 15 % increase in L-lac-
tate yield from glucose compared with the parental
strain. Zhang et al. [68] proceeded in the direct produc-
tion of lactate from cellulose as the sole carbon source
without any other organic nutrient by recombinant cellu-
lolytic B. subtilis. Overexpression of the endoglucanase
BsCel5 enabled B. subtilis to grow on solid cellulosic
materials as the sole carbon source for the first time.
Furthermore, the specific activity of BsCel5 on regener-
ated amorphous cellulose (RAC) and its expression/se-
cretion level in B. subtilis was increased by two-round
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alpha-acetolactate synthase gene (alsS) in the 2,3-butane-
diol pathway was knocked out.
Corynobacterium glutamicum
The Gram-positive bacterium C. glutamicum was discov-
ered 50 years ago as a natural overproducer of glutamate.
Today, it is used for the industrial production of more
than 2 million tons of amino acids (glutamate, lysine and
tryptophan) per year [69]. Decades of intensive research
triggered by the economical importance of the micro-
organism, highlighted its metabolism [70-73] and pro-
vided the complete genome sequence [74] along with
efficient genomic approaches and metabolic engineering
strategies aiming at novel and advanced bioprocesses.
The recent review by Wittmann [69] provides a rich
source of information on metabolic engineering strat-
egies applied to C. glutamicum over the last years.
The CCM in C. glutamicum involving glycolysis, the
PP pathway, the TCA cycle and the anaplerotic and glu-
coneogenic reactions are intensively studied and well
known topics today [69]. The PP pathway and its role in
NADPH regeneration for lysine biosynthesis has been
the subject of a number of important studies. The PP
pathway in C. glutamicum is mainly regulated by the
ratio of NADPH/NADP concentrations and the activity
of G6PDH [75]. Together with G6PDH, 6PGDH and iso-
citrate dehydrogenase, they represent the main NADPH
sources in this organism [76]. Intracellular metabolite
concentrations and specific enzyme activities during ly-
sine overproduction in two isogenic leucine auxotrophic
strains, which differed only in the regulation of their as-
partate kinases (a key enzyme of the lysine production
pathway), were compared by Moritz et al. [76]. Analyses
confirmed that NADPH regeneration in the PP pathway
is essential for lysine biosynthesis in C. glutamicum.
Marx et al. [77] constructed a phosphoglucose isomerase
(pgi) mutant strain of C. glutamicum to redirect the car-
bon flux through the PP pathway. L-lysine production
increased as well as by-product formation and growth
rate, a common feature of pgi mutants due to disturbed
metabolism of NADPH.
Various approaches have aimed at increasing the flux
through the PP pathway. Overexpression of the fbp gene,
encoding fructose 1,6-bisphosphatase, increased lysine yield
on glucose, sucrose and fructose up to about 40 % by en-
hancing the PP pathway flux by 10 % [78]. Another major
target approached was the zwf gene, encoding G6PDH, the
overexpression of which resulted in increased lysine pro-
duction on different carbon sources [79]. Modification of
the regulatory properties of the PP pathway enzymes led
also to significant increases of the flux through the PP
pathway [79]. Introduction of 12 defined genome-based
changes in genes encoding central metabolic enzymesredirected major carbon fluxes as desired towards the opti-
mal pathway usage predicted by in silico modelling in the
work of Becker et al. [80]. The engineered C. glutamicum
produced lysine with a high yield of 0.55 g /g glucose, a
titer of 120 g /L lysine and a productivity of 4.0 g /L/h in
fed-batch culture. The specific glucose uptake rate of the
wild type was completely maintained during the engineer-
ing process, providing a highly viable producer. This is the
first report of a rationally derived lysine production strain
that may be competitive with industrial applications.
For anaplerotic replenishment of the TCA cycle, C.
glutamicum exhibits-in contrast to many other organ-
isms- pyruvate carboxylase (pyc) and PEP carboxylase
(ppc) as carboxylating enzymes [73]. In addition to the
activities of the above C3-carboxylating enzymes, C. glu-
tamicum possesses three C4-decarboxylating enzymes
converting oxaloacetate or malate to PEP or pyruvate.
The individual flux rates in this complex anaplerotic
node were investigated by using [13 C]-labelled sub-
strates. The results revealed that both carboxylation and
decarboxylation occur simultaneously in C. glutamicum
and a high cyclic flux of oxaloacete via PEP to pyruvate
was found [73]. The PEP-pyruvate-oxaloacetate node in
C. glutamicum has been discussed extensively in the re-
view by Sauer and Eikmanns [6]. Since a variety of amino
acids originate their biosynthesis from the PEP-pyruvate-
oxaloacetate node, the enzymes in this node and in par-
ticular the anaplerotic enzymes have been regarded as
important targets for metabolic engineering of C. gluta-
micum. Overexpression of pyc resulted in seven-fold in-
crease of glutamate production as well as increased
lysine accumulation, while abolition of pyruvate carb-
oxylase activity resulted in significantly lower amino acid
formation [72]. “Genome-based strain reconstruction”
confirmed the role of pyc in lysine production [81]. How-
ever, Koffas et al. [82] showed that overexpression of pyc
increased growth but decreased the specific productivity
of lysine. Simultaneous expression of aspartate kinase
abolished the deficiency and yielded more than 250 % in-
crease of the lysine specific productivity without affecting
the growth rate or final cell density of the culture [83].
Another important reaction for the production of amino
acids derived from the TCA cycle is the PEP-carboxyki-
nase (pck) reaction. In contrast to the situation found
with pyruvate carboxylase [81], abolition of the PEP car-
boxykinase activity led to an increase in glutamate pro-
duction by 440 % and lysine production by 120 % while
increasing its activity led to significantly reduced produc-
tivities (40 % and 20 %, respectively) [84].
Streptomyces spp
The fame of streptomycetes as efficient producers of anti-
biotics started with the discovery of actinomycin in 1940,
followed by streptomycin in 1943 [85]. Today, two-thirds
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mycetes. Bacteria of the genus Streptomyces have been ex-
tensively isolated since 1940 and today the chance of
discovering new antibiotics from them is increasing.
Secondary metabolic pathways have been until recently
the obvious choice for investigations of strain manipula-
tion and yield improvement in Streptomyces. During the
last years, genetic manipulation of biosynthetic pathways
offered new tools and perspectives. The Embden-Meyer-
hof-Parnas (EMP) pathway, the PP pathway and the TCA
cycle are present in a number of Streptomyces species [86]
but until recently, the enzymes controlling the primary
metabolic pathways have been rather ignored. The prod-
uctivity of secondary metabolites is mainly determined by
the availability of biosynthetic precursors (e.g. acetyl-CoA
and malonyl-CoA). Primary metabolism supplies these
precursors and therefore, identification and engineering of
the enzymes that regulate the carbon flux through the net-
work of reactions of the CCM can increase the availability
of precursors [87]. Moreover, metabolic flux rebalancing
for precursor-directed biosynthesis provided novel pro-
ducts with improved properties [88].
Optimized metabolic flux distributions were calculated
for the production of actinorhodin (ACT) [89] and the
calcium dependent antibiotic daptomycin (CDA), both
produced by S. coelicolor, for various nutrient limitations
[90]. Performing metabolic flux analysis, Kim et al. [89]
found that CDA production was concomitant with
growth and production in batch culture was affected by
the oxidative branch of the PP pathway, the shikimate
biosynthesis, the oxoglutarate fluxes and nitrogen assimi-
lation. Metabolic flux analysis in chemostat cultures of S.
lividans grown on glucose or gluconate showed
increased carbon flux through glycolysis and the PP
pathway while the synthesis of both ACT and undecyl-
prodigiosin (RED) was inverse to the flux through the PP
pathway [91]. Deletions of either of two genes zwf1 and
zwf2 coding for isoenzymes of the initial enzyme of the
PP pathway G6PDH, resulted in more efficient utilization
of glucose via glycolysis and increased acetyl-CoA pre-
cursor pools that led to four-fold increased production
of both ACT and RED by S. lividans [92].
Ryu and co-workers [93] investigated the roles of key
enzymes in central carbon metabolism in the context of
increased ACT production by S. coelicolor. Genes encod-
ing G6PDH (either zwf1 or zwf2) and phosphoglucomutase
(pgm) were deleted and those for the acetyl-CoA carboxyl-
ase (ACCase) were overexressed. G6PDH encoded by zwf2
was found to play a more important role than the encoded
by zwf1 in determining the carbon flux to ACT. The pgm-
deleted mutant produced abutant glycogen but was
impaired in ACT production. Finally, overexpression of
ACCase resulted in more rapid utilization of glucose and
increased efficiency of its conversion to ACT. It wasconcluded therefore that the carbon storage metabolism
plays a significant role in precursor supply for ACT pro-
duction and that manipulation of the CCM can lead to
increased ACT production by S. coelicolor.
The first reported application of genetic engineering to
channel precursor flux to improve clavulanic acid produc-
tion by S. clavuligerus was that by Li and Townsend [94].
Clavulanic acid biosynthesis is initiated by the condensa-
tion of L-arginine and D-glyceraldehyde-3-phosphate
(G3P). Two genes (gap1 and gap2) whose protein products
are distinct glyceraldehyde-3-phosphate dehydrogenases
(GAPDHs) were inactivated in S. clavuligerus by targeted
gene disruption. A two-fold increase in production of cla-
vulanic acid was obtained when gap1 was disrupted, and
reversed by complementation. Addition of arginine to the
cultured mutant further improved clavulanic acid produc-
tion giving a greater than two-fold increase over wild type,
suggesting that arginine became limiting for biosynthesis.
Lactococcus lactis and other lactic acid bacteria
Apart from their use as starter cultures in the industrial
manufacture of fermented food products, lactic acid bac-
teria (LAB) are also used in a variety of industrial appli-
cations, e.g. production of lactic acid, antimicrobial
peptides, stereoisomers of lactic acid, high-value metabo-
lites involved in flavor, texture or health applications and
probiotic products. Their industrial importance along
with some characteristics, such as their small genome
size (~2-3 Mb) and simple energy and carbon metabol-
ism, make them promising targets of metabolic engineer-
ing strategies. Such strategies have mainly focused either
on rerouting of pyruvate metabolism to produce import-
ant fermentation end products [95,96] or on the complex
biosynthetic pathways leading to the production of exo-
polysaccharides and vitamins [97,98]. Attempts to ma-
nipulate the central carbon metabolism in these bacteria
are rather limited compared to the above.
Among LAB, Lactococcus lactis is by far the most ex-
tensively studied organism. The relative simplicity of L.
lactis metabolism that converts sugars to pyruvate via
the glycolytic pathway (Figure 2) generating energy
through substrate level phosphorylation, the availability
of numerous genetic tools [99] and the knowledge of its
complete genome sequence [100], make it an attractive
target for metabolic engineering and the development of
effective cell factories [101].
L. lactis shows homolactic metabolism when growing in
rapidly metabolized sugars with more than 90 % of the
metabolized sugar being converted to lactic acid. Deviation
from homolactic fermentation is observed under aerobic
conditions [102,103] or during the metabolism of galactose
or maltose [104,105]. Regulation of glycolysis and the shift
between different fermentation modes have attracted con-
siderable attention and have been extensively studied [106-
Figure 2 Glycolysis, the sequence of enzymatic reactions in the conversion of glucose to pyruvate and finally, to fermentation
products. In red letters, are the enzymes involved. Highlighted, are the components exchanged between oxidation or reduction reactions. The
number of the produced molecules is given, highlighted in green.
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the role of phosphofructokinase (PFK) on glycolytic flux in
L. lactis, show that this enzyme plays an important role
since glycolytic and lactate fluxes were decreased propor-
tionally by a two-fold reduction of PFK activity. A key role
was also attributed to PFK with regard to the glycolytic
flux control by Neves et al. [103]. Papagianni and co-work-
ers [112] showed that the control of the glycolytic flux
resides to a large extend in processes outside the glycolytic
pathway itself, like glucose transport and the ATP consum-
ing reactions, and allosteric properties of key enzymes like
PFK have a significant influence on the control. Extending
their work, Papagianni and Avramidis [112,113] con-
structed L. lactis strains with altered PFK activity, by clon-
ing the pfkA gene from Aspergillus niger or its truncatedversion pfk13 that encodes a shorter PFK1 fragment, and
studied the effects of increased PFK activity on the glyco-
lytic capacity of L. lactis and lactic acid production. The
results demonstrated the direct effect of PFK activity on
the glycolytic flux in L. lactis since a two-fold increase in
specific PFK activity (from 7.1 to 14.5 U/OD600) resulted
in a proportional increase of the maximum specific rates
of glucose uptake (from 0.8 to 1.7 μMs-1 g CDW-1) and
lactate formation (from 15 to 22.8 g lactate (g CDW)-1 h-1).
It has been shown by Luesink et al. [114] that the
glycolytic flux in L. lactis is also affected by the carbon
catabolite protein (CcpA) which besides its role in catab-
olite repression also regulates sugar metabolism through
activation of the las operon (encoding the glycolytic
enzymes PFK and PYK, and LDH). Inactivation of the
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pression level of the las operon genes that resulted in a
shift from homolactic to mixed acid fermentation [114].
The unique to LAB CcpA-mediated activation of the las
operon genes has also been observed in Lactobacillus
plantarum and Streptococcus thermophilus [99].
Because of its presence in milk and milk-based industrial
media, lactose metabolism has been given considerable at-
tention. In many lactococcal strains, the genes involved in
lactose metabolism (lac operon) are plasmid encoded and
the lactose mini-plasmid pMG820 is the best described so
far [115]. The plasmid contains the genes involved in the
lactose-PTS transport (lacEF), lactose-6P hydrolysis (lacG)
and the tagatose-6P pathway (lacABCD) (Figure 3). In
1985, Thompson et al. [116] constructed by classical muta-
genesis a double mutant of L. lactis that lacked both the
glucokinase gene (glk) and the mannose-PTS system
involved in glucose import. Growth of that strain on lac-
tose involved the conversion of the galactose-6P moiety
via the tagatose-6P pathway while the glucose moiety of
the disaccharide remained unphosphorylated and secreted.
The lack of the mannose-PTS in that strain prevented the
subsequent utilization of the secreted glucose. Although
the exact mechanism of the engineering is unclear because
of the application of random mutagenesis, this early work
by Thompson et al. [116] shows how the galactose and
glucose metabolism in lactose grown L. lactis can be com-
pletely separated.Figure 3 Metabolic pathways involved in carbohydrate metabolism inEngineering of carbon distribution between glycolysis
and sugar nucleotide biosynthesis is of special importance
for the production of UDP-glucose and other activated
sugars that serve as precursors for exopolysaccharide (EPS)
biosynthesis. EPS from LAB have been given considerable
attention recently as they contribute to the development of
texture in fermented products; they provide health benefits
to consumers (prebiotics) and also protect their producer
organisms against bacteriophages and various environmen-
tal stresses [99]. UDP-glucose, the most important pre-
cursor in EPS biosynthesis, is generated from the
glycolytic intermediate glucose-6P by a phosphogluco-
mutase (encoded by the pgmU gene). The intermediate
product glucose-1P serves as building block for poly-
mers and it is converted to UDP-glucose by a phos-
phorylase (encoded by the galU gene). Metabolic
engineering strategies aiming at overproduction of
UDP-glucose have focused on overexpression of the
pathway involved genes galU and pgmU [117,118].
However, decreased activity levels of the key glycolytic
enzyme PFK resulted in increased UDP-glucose forma-
tion in L. lactis grown on glucose [117] but not on lac-
tose [111], the latter indicating that the type of
carbohydrate might affect the pathway flux.
Conclusions
As shown in this review, significant improvement in
engineering the central carbon metabolism inLactococcus lactis.
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ing recent years. The examples presented, exemplify
the power of metabolic engineering by applying differ-
ent methods and approaches, e.g. inactivation, overex-
pression, redox engineering or even in some cases
engineering global control. The quantitative assess-
ment of metabolic fluxes through the central carbon
metabolism and of the flux distribution at metabolic
branch points, provide detailed information not only
for single reactions but also for whole pathways of a
variety of bacteria. This information is expanding rap-
idly by the use of genome-based approaches to new
areas and the discovery of novel metabolites especially
in the case of Streptomycetes and lactic acid bacteria.
However, there is still lack of knowledge regarding
the prediction of responses of these bacteria to vari-
ous changes and different conditions. The goal
remains to have a global overview of the metabolism
of producer strains and accordingly to proceed in the
construction of robust strains capable of efficiently
producing the desired metabolites. In this view, it is
expected that developing System Biology approaches
that take into account the gathered information on
central carbon metabolism regulation and connect it
to global regulation along with improved computa-
tional approaches, will provide the opportunities to
create efficient cell-factories tailor-made for the pro-
duction of industrially important metabolites.
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